相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells
Zhenjie Yin et al.
ACTA HISTOCHEMICA (2012)
Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
Carolyn Algire et al.
CANCER PREVENTION RESEARCH (2012)
NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells
S. Yoon et al.
ONCOGENE (2012)
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Guilherme Z. Rocha et al.
CLINICAL CANCER RESEARCH (2011)
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
C-C. Lin et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells
Sukanya Phalitakul et al.
PHARMACOLOGICAL RESEARCH (2011)
Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers
Giang Huong Nguyen et al.
Cancers (2011)
STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells
Sarah Yoon et al.
AUTOPHAGY (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Metformin: A Therapeutic Opportunity in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2010)
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
A. Nerstedt et al.
DIABETOLOGIA (2010)
Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans
Sabine Lagger et al.
EMBO JOURNAL (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
Tingyan Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade
Jianhui Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Vuk Stambolic et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
Sonia Correia et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
Mette Munk Jensen et al.
BMC MEDICAL IMAGING (2008)
AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway
Ling-Zhi Liu et al.
CANCER RESEARCH (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition
Du-Hyong Cho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion
H-H Yeh et al.
ONCOGENE (2006)
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process
D Detaille et al.
DIABETES (2005)
One hundred years of lung cancer
SG Spiro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Metformin inhibits mitochondrial permeability transition and cell death:: a pharmacological in vitro study
B Guigas et al.
BIOCHEMICAL JOURNAL (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
分享论文
